MDM2 and MDMX can interact differently with ARF and members of the p53 family

被引:73
作者
Wang, XQ
Arooz, T
Siu, WY
Chiu, CHS
Lau, A
Yamashita, K
Poon, RYC
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Life Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
ARF; MDM2; MDMX; p53; p63; p73; tumor suppressor;
D O I
10.1016/S0014-5793(01)02124-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the p53 family of transcription factors have essential roles in tumor suppression and in development, MDM2 is an essential regulator of p53 that can inhibit the transcriptional activity of p53, shuttle p53 out of the nucleus, and target p53 for ubiquitination-mediated degradation. Little is known about the interaction and selectivity of different members of the p53 family (p53, p63, and p73) and the MDM2 family (MDM2 and MDMX). Here we show that the transcriptional activities of p53 and p73, but not that of p63, were inhibited by both MDM2 and MDMX. Consistent with these, we found that MDMX can physically interact with p53 and p73, but not with p63, Moreover, ectopically expressed MDM2 and MDMX could induce alterations in the subcellular localization of p73, but did not affect the subcellular localization of p53 and p63. Finally, we demonstrate that while ARF can interact with MDM2 and inhibit the regulation of p53 by MDM2. no interaction was found between ARF and MDMX. These data reveal that significant differences and selectivity exist between the regulation of different members of the p53 family by MDM2 and MDMX. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [1] Mdm2 and MdmX partner to regulate p53
    Wang, Xinjiang
    Jiang, Xuejun
    FEBS LETTERS, 2012, 586 (10) : 1390 - 1396
  • [2] Regulation of p53: a collaboration between Mdm2 and MdmX
    Pei, Dongsheng
    Zhang, Yanping
    Zheng, Junnian
    ONCOTARGET, 2012, 3 (03) : 228 - 235
  • [3] MDM2 and MDMX: alone and together in regulation of p53
    Shadfan, Miriam
    Lopez-Pajares, Vanessa
    Yuan, Zhi-Min
    TRANSLATIONAL CANCER RESEARCH, 2012, 1 (02) : 88 - 99
  • [4] Transcription factors that interact with p53 and Mdm2
    Inoue, Kazushi
    Fry, Elizabeth A.
    Frazier, Donna P.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1577 - 1585
  • [5] The roles and regulation of MDM2 and MDMX: it is not just about p53
    Klein, Alyssa M.
    de Queiroz, Rafaela Muniz
    Venkatesh, Divya
    Prives, Carol
    GENES & DEVELOPMENT, 2021, 35 (9-10) : 575 - 601
  • [6] MDM2/MDMX: Master negative regulators for p53 and RB
    Hu, Linshan
    Zhang, Haibo
    Bergholz, Johann
    Sun, Shengnan
    Xiao, Zhi-Xiong Jim
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)
  • [7] Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
    Mrkvova, Zuzana
    Uldrijan, Stjepan
    Pombinho, Antonio
    Bartunek, Petr
    Slaninova, Iva
    MOLECULES, 2019, 24 (11):
  • [8] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006
  • [9] MdmX inhibits ARF mediated Mdm2 sumoylation
    Ghosh, M
    Weghorst, K
    Berberich, SJ
    CELL CYCLE, 2005, 4 (04) : 604 - 608
  • [10] Differential binding of p53 and nutlin to MDM2 and MDMX Computational studies
    Joseph, Thomas Leonard
    Madhumalar, Arumugam
    Brown, Christopher John
    Lane, David P.
    Verma, Chandra
    CELL CYCLE, 2010, 9 (06) : 1167 - 1181